Stem Cell Network
Overview
Stem Cell Network is a Canadian not-for-profit organization that supports and funds translational research in stem cells and regenerative medicine, including early-stage clinical trials and pre-seed to seed-stage biotechnology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BoutIQ Solutions | Jun 2025 | Grant | Lead |
| Morphocell Technologies | Jun 2025 | Grant | Co-investor |
| RejuvenRx Inc. | Sep 2026 | Grant | Lead |
| OrganoBiotech | - | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Stem Cell Network based?
Stem Cell Network is headquartered in Ottawa, Ontario, Canada.
When was Stem Cell Network founded?
Stem Cell Network was founded in 2001.
How many portfolio companies does Stem Cell Network have?
Stem Cell Network has 4 portfolio companies in Caplight's dataset.
What are some companies in Stem Cell Network's portfolio?
Portfolio companies visible on Caplight include BoutIQ Solutions, Morphocell Technologies, RejuvenRx Inc., OrganoBiotech.
What was Stem Cell Network's most recent investment shown here?
Stem Cell Network's most recent investment in this portfolio sample was in RejuvenRx Inc. in 2026.
What sectors does Stem Cell Network focus on?
Stem Cell Network focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Stem Cell Network focus on?
Stem Cell Network typically invests at the MultiStage stage.